Appreciate the kind words and you are right Theralase is speculative also. But, only on their cancer PDC technology.
Theralase Technologies has 20 years of successfully producing revenue on the Cold Laser side of the house and are introducing their next generation laser (TLC 2000) which will significantly increase revenue for them. Moreover, this revenue will help support clinical trials of their PDC cancer technology. The revenue alone from the laser business supports a much higher PPS than the current trading value, so that alone is good reason to do a little dd. But the PDC cancer technology could be the golden goose.
More important than all that for me is managements experience, character, credibility and strategy. In this area Theralase excels. Consistent communication with investors on all activities.
Titan has failed for me twice in 5 years and won't give me the time of day (no consistent investor updates). Pumpers on this board always say "just believe them, this is going great and will be a huge success". First rule of my investing strategy "Trust but verify". I haven't been able to do either for some time here.
I still wish all the "decent" folks here the best of luck however.
News 
Market Data 
Discover 
